{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae Multi-Panel DOA Dip Card Tests",
        "Chemtrue\u00ae Multi-Panel DOA Dip Card with OPI 2000 Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K142580",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102203",
        "K111322",
        "K121339",
        "K123080"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "LCM",
        "DIO",
        "LDJ",
        "LAF",
        "DJG",
        "DIS",
        "JXM",
        "DJC",
        "DJR",
        "DNK"
    ],
    "Summary Letter Date": "November 3, 2014",
    "Summary Letter Received Date": "November 4, 2014",
    "Submission Date": "November 20, 2014",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3650",
        "21CFR862.3870",
        "21CFR862.3170",
        "21CFR862.3150",
        "21CFR862.3620",
        "21CFR862.3640"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cocaine and metabolites test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Cannabinoids test system",
        "Benzodiazepines test system",
        "Barbiturates test system",
        "Methadone test system",
        "Morphine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Cocaine",
        "Methamphetamine",
        "Morphine",
        "Opiates",
        "Phencyclidine",
        "Marijuana",
        "Benzodiazepines",
        "Barbiturates",
        "Ecstasy (MDMA)",
        "Methadone",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Dip Card",
        "Test",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue Multi-Panel DOA Dip Card Tests and Chemtrue Multi-Panel DOA Dip Card with OPI 2000 Tests for qualitative detection of multiple drugs of abuse in urine by lateral flow immunoassay.",
    "Indications for Use Summary": "Qualitative detection of Amphetamine, Cocaine, Marijuana, Morphine, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone (and Opiates 2000 for OPI 2000 Tests) drugs in human urine for prescription and over-the-counter use.",
    "fda_folder": "Toxicology"
}